A. Mattsson, Intrahepatic
cholestasis of pregnancy: relationships between bile acid levels
and fetal complication rates, Hepatology, vol. 40, no. 2, pp. 467
474, 2004.
[25] A. Ingber, Atopic eruption of pregnancy, Journal of the Euro-
pean Academy of Dermatology and Venereology, vol. 24, no. 8, p.
984, 2010.
[26] E. Garca-Gonz alez, R. Ahued-Ahued, E. Arroyo, D. Montes-
De-Oca, and J. Granados, Immunology of the cutaneous
disorders of pregnancy, International Journal of Dermatology,
vol. 38, no. 10, pp. 721729, 1999.
[27] C.-C. Chi, G. Kirtschig, W. Aberer et al., Evidence-based
(S3) guideline on topical corticosteroids in pregnancy, British
Journal of Dermatology, vol. 165, no. 5, pp. 943952, 2011.
[28] C. C. Chi, S. H. Wang, R. Mayon-White, and F. Wojnarowska,
Pregnancy outcomes afer maternal exposure to topical corti-
costeroids: a UK population-based cohort study, JAMA Der-
matology, vol. 149, no. 11, pp. 12741280, 2013.
[29] R. Treudler, Allergische Erkrankungen bei Schwangeren, Der
Hautarzt, vol. 61, no. 12, pp. 10271033, 2010.
[30] S. M. Gilboa, M. J. Strickland, A. F. Olshan, M. M. Werler,
and A. Correa, Use of antihistamine medications during early
pregnancy and isolated major malformations, Birth Defects
Research Part A, vol. 85, no. 2, pp. 137150, 2009.
[31] R. Serreau, M. Komiha, F. Blanc, F. Guillot, and E. Jacqz-
Aigrain, Neonatal seizures associated with maternal hydrox-
yzine hydrochloride inlate pregnancy, Reproductive Toxicology,
vol. 20, no. 4, pp. 573574, 2005.
[32] C. Goldnau, A. K oninger, and R. Kimmig, Das auere Genitale
der Frau, Der Urologe, vol. 49, no. 12, pp. 14961502, 2010.